论文信息 - FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer. - 字舞流文

FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.

K. Goldberg | R. Pazdur | M. Theoret | J. Beaver | P. Kluetz | H. Singh | P. Mishra-Kalyani | Erin A. Larkins | L. Pai-Scherf | Lisa Rodriguez | Xiaoxue Li | L. Mathieu | Jonathon Vallejo | S. Shah | Erin Larkins | Kirsten B. Goldberg | Luckson N Mathieu | Lisa R Rodriguez | E. Larkins